Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

G 4460

Drug Profile

G 4460

Alternative Names: c-myb antisense oligonucleotide G4460; G4460; INX 3001; INXC 3001; LR3001

Latest Information Update: 09 Mar 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Temple University
  • Developer Genta (CEASED); University of Pennsylvania
  • Class Antineoplastics; Antisense oligonucleotides
  • Mechanism of Action Proto oncogene proteins c myb inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Chronic myeloid leukaemia
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Chronic myeloid leukaemia; Leukaemia

Most Recent Events

  • 20 May 2008 Discontinued - Phase-I for Leukaemia in USA (IV)
  • 20 May 2008 Discontinued - Preclinical for Chronic myeloid leukaemia in USA (Parenteral)
  • 26 Oct 2006 Phase-I clinical trials in Leukaemia in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top